Adhesive Lipophilic Gels Delivering Rapamycin Prevent Oral Leukoplakia from Malignant Transformation

Overview

Journal Mater Today Bio

Specialty Biomedical Engineering

Date 2024 Nov 11

PMID 39525395

Authors

Yuqi Du

Tiannan Liu

Tingting Ding

Xin Zeng

Qianming Chen

Hang Zhao

Affiliations

Soon will be listed here.

Abstract

Oral leukoplakia (OLK) is the most emblematic oral potentially malignant disorder that may precede the diagnosis of oral squamous cell carcinoma (OSCC) and has an overall malignant transformation rate of 9.8 %. Early intervention is crucial to reduce the malignant transformation rate from OLK to OSCC but the lack of effective local pharmaceutical preparations poses a challenge to clinical management. Rapamycin is speculated to prevent OLK from carcinogenesis and its inherent lipophilicity facilitates its penetration into stratum corneum. Nevertheless, hydrophilic hydrogels frequently encounter challenges when attempting to deliver lipophilic drugs. Furthermore, the oral cavity presents a complex environment defined by oral motor functions, saliva secretion cycles, dynamic fluctuations, and protective barriers comprising mucus and lipid layers. Consequently, addressing issues of muco-penetration and muco-adhesion is imperative for developing an effective drug delivery system aiming at delivering rapamycin to target oral potentially malignant disorders. Here, a dual-function hydrogel drug delivery system integrating adhesion and lipophilicity was successfully developed based on polyvinyl alcohol (PVA) and dioleoyl phosphatidylglycerol (DOPG) via dynamic boronic ester bonds. Rheological experiments based on orthogonal design revealed that PVA-DOPG hydrogels exhibited ideal adhesive strength (around 6 kPa) and could adhere to various surfaces in both dry and wet conditions. PVA-DOPG hydrogels also significantly promoted lipophilic molecules' penetration into stratum corneum (integrated fluorescence density of 6.95 ± 0.52 × 10 and mean fluorescence depth of 0.96 ± 0.07 mm) of ex-vivo porcine buccal mucosa ( < 0.001). Furthermore, PVA-DOPG hydrogels incorporating rapamycin inhibited malignant transformation of OLK mouse model induced by 4-Nitroquinoline N-oxide (4-NQO), distinct improvements in survival (the neoplasm incidence density at the 40th day is 0.0091) ( < 0.05), decrease in neoplasm incidence density of 36.36 % and inhibition rate in neoplasm volume of 75.04 ± 33.67 % have been demonstrated, suggesting the hydrogels were valuable candidates for potential applications in the management of OLK.

References

Hanna G, Villa A, Nandi S, Shi R, ONeill A, Liu M . Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial. JAMA Oncol. 2023; 10(1):32-41. PMC: 10654930. DOI: 10.1001/jamaoncol.2023.4853. View

Patel J, Nguyen S, Ogretmen B, Gutkind J, Nathan C, Day T . mTOR inhibitor use in head and neck squamous cell carcinoma: A meta-analysis on survival, tumor response, and toxicity. Laryngoscope Investig Otolaryngol. 2020; 5(2):243-255. PMC: 7178455. DOI: 10.1002/lio2.370. View

Martins de Oliveira P, Bavaresco V, Silveira-Filho L, Schenka A, de Souza Vilarinho K, de Oliveira Severino E . Use of a novel polyvinyl alcohol membrane as a pericardial substitute reduces adhesion formation and inflammatory response after cardiac reoperation. J Thorac Cardiovasc Surg. 2013; 147(4):1405-10. DOI: 10.1016/j.jtcvs.2013.07.021. View

Aslam Khan M, Yaqoob Z, Ansari M, Razak S, Raza M, Sajjad A . Chitosan/Poly Vinyl Alcohol/Graphene Oxide Based pH-Responsive Composite Hydrogel Films: Drug Release, Anti-Microbial and Cell Viability Studies. Polymers (Basel). 2021; 13(18). PMC: 8471615. DOI: 10.3390/polym13183124. View

Du X, Gao N, Song X . Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability. Drug Deliv. 2021; 28(1):252-260. PMC: 7850345. DOI: 10.1080/10717544.2021.1872742. View

Landh E, Moir L, Gomes Dos Reis L, Traini D, Young P, Ong H . Inhaled rapamycin solid lipid nano particles for the treatment of Lymphangioleiomyomatosis. Eur J Pharm Sci. 2019; 142:105098. DOI: 10.1016/j.ejps.2019.105098. View

Schmedlen R, Masters K, West J . Photocrosslinkable polyvinyl alcohol hydrogels that can be modified with cell adhesion peptides for use in tissue engineering. Biomaterials. 2002; 23(22):4325-32. DOI: 10.1016/s0142-9612(02)00177-1. View

Schreiber K, Arriola Apelo S, Yu D, Brinkman J, Velarde M, Syed F . A novel rapamycin analog is highly selective for mTORC1 in vivo. Nat Commun. 2019; 10(1):3194. PMC: 6642166. DOI: 10.1038/s41467-019-11174-0. View

Postle A, Heeley E, Wilton D . A comparison of the molecular species compositions of mammalian lung surfactant phospholipids. Comp Biochem Physiol A Mol Integr Physiol. 2001; 129(1):65-73. DOI: 10.1016/s1095-6433(01)00306-3. View

10.

Chen L, Zheng B, Xu Y, Sun C, Wu W, Xie X . Nano hydrogel-based oxygen-releasing stem cell transplantation system for treating diabetic foot. J Nanobiotechnology. 2023; 21(1):202. PMC: 10294352. DOI: 10.1186/s12951-023-01925-z. View

11.

Marco-Dufort B, Janczy J, Hu T, Lutolf M, Gatti F, Wolf M . Thermal stabilization of diverse biologics using reversible hydrogels. Sci Adv. 2022; 8(31):eabo0502. PMC: 9355364. DOI: 10.1126/sciadv.abo0502. View

12.

Chang Y, Hsu Y, Wu T, Huang C, Liou L, Chiu Y . Regulation of estrogen receptor α function in oral squamous cell carcinoma cells by FAK signaling. Endocr Relat Cancer. 2014; 21(4):555-65. DOI: 10.1530/ERC-14-0102. View

13.

Kim S, Kim S, Klempner S, Yoon J, Kim N, Ahn S . Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition. Ann Oncol. 2016; 28(3):547-554. DOI: 10.1093/annonc/mdw669. View

14.

Kuriakose M, Ramdas K, Dey B, Iyer S, Rajan G, Elango K . A Randomized Double-Blind Placebo-Controlled Phase IIB Trial of Curcumin in Oral Leukoplakia. Cancer Prev Res (Phila). 2016; 9(8):683-91. DOI: 10.1158/1940-6207.CAPR-15-0390. View

15.

Nieuw Amerongen A, Veerman E . Saliva--the defender of the oral cavity. Oral Dis. 2002; 8(1):12-22. DOI: 10.1034/j.1601-0825.2002.1o816.x. View

16.

Chaturantabut S, Shwartz A, Evason K, Cox A, LaBella K, Schepers A . Estrogen Activation of G-Protein-Coupled Estrogen Receptor 1 Regulates Phosphoinositide 3-Kinase and mTOR Signaling to Promote Liver Growth in Zebrafish and Proliferation of Human Hepatocytes. Gastroenterology. 2019; 156(6):1788-1804.e13. PMC: 6532055. DOI: 10.1053/j.gastro.2019.01.010. View

17.

Murthy S, Zhao Y, Hui S, Sen A . Synergistic effect of anionic lipid enhancer and electroosmosis for transcutaneous delivery of insulin. Int J Pharm. 2006; 326(1-2):1-6. DOI: 10.1016/j.ijpharm.2006.06.039. View

18.

Xie X, Zhang Y, Liang Y, Wang M, Cui Y, Li J . Programmable Transient Supramolecular Chiral G-quadruplex Hydrogels by a Chemically Fueled Non-equilibrium Self-Assembly Strategy. Angew Chem Int Ed Engl. 2021; 61(9):e202114471. DOI: 10.1002/anie.202114471. View

19.

Netsomboon K, Bernkop-Schnurch A . Mucoadhesive vs. mucopenetrating particulate drug delivery. Eur J Pharm Biopharm. 2015; 98:76-89. DOI: 10.1016/j.ejpb.2015.11.003. View

20.

Cromwell O, Chung J, Guan Z . Malleable and Self-Healing Covalent Polymer Networks through Tunable Dynamic Boronic Ester Bonds. J Am Chem Soc. 2015; 137(20):6492-5. DOI: 10.1021/jacs.5b03551. View